Phibro Animal Health reported $232.38M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Align Technology ALGN:US USD 746.69M 34.66M
Ani Pharmaceuticals ANIP:US USD 88.82M 2.05M
Aurora Cannabis Inc ACB:CN CAD 103.76M 571.03M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Canopy Growth Corp WEED:CN CAD 277.53M 1.69B
Corcept Therapeutics CORT:US USD 69.79M 2.16M
Depomed DEPO:US USD 27.78M 3.44M
Eli Lilly And LLY:US USD 5.27B 12.8M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Henry Schein HSIC:US USD 2.86B 46M
Idexx Laboratories IDXX:US USD 596.83M 84.65M
Knight Therapeutics Inc GUD:CN CAD 83.61M 10.69M
Lannett LCI:US USD 88.11M 64.04M
Merk MRK:US USD 10.97B 1.31B
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Patterson Companies PDCO:US USD 1.57B 77.69M
Prestige Brands PBH:US USD 204.89M 14.84M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
Zoetis ZTS:US USD 1.34B 47M